Adherence-enhancing intervention and relapse in childhood acute lymphoblastic leukemia: results from the Children’s Oncology Group randomized trial ACCL1033

This publication has 12 references indexed in Scilit:

• Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia
  JAMA Network Open, 2020
• DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial
  The Lancet Oncology, 2017
• Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232
  Blood, 2015
• Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia
  JAMA Oncology, 2015
• 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study
  Blood, 2014
• A Grounded Theory of the Process of Adherence to Oral Chemotherapy in Hispanic and Caucasian Children and Adolescents With Acute Lymphoblastic Leukemia
  Journal of Pediatric Oncology Nursing, 2011
• Prognostic Importance of 6-Mercaptopurine Dose Intensity in Acute Lymphoblastic Leukemia
  Blood, 1999
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
  Statistics in Medicine, 1999
• Compliance assessed by the Medication Event Monitoring System.
  Archives of Disease in Childhood, 1991
• Systemic Exposure to Mercaptopurine as a Prognostic Factor in Acute Lymphocytic Leukemia in Children
  New England Journal of Medicine, 1990